Skip to main content

M Gopalakrishnan

First name:
M
Last name:
Gopalakrishnan
Briggs, C. ., Anderson, D. ., Brioni, J. ., Buccafusco, J. ., Buckley, M. ., Campbell, J. ., … Arneric, S. . (1969). Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo. Pharmacology, Biochemistry, and Behavior, 57(1-2), 231-41. https://doi.org/10.1016/s0091-3057(96)00354-1 (Original work published 1969)
Kalaria, S. ., McElroy, S. ., Gobburu, J. ., & Gopalakrishnan, M. . (2020). An Innovative Disease-Drug-Trial Framework to Guide Binge Eating Disorder Drug Development: A Case Study for Topiramate. Clinical and Translational Science, 13(1), 88-97. https://doi.org/10.1111/cts.12682
Goyal, R. ., Kalaria, S. ., McElroy, S. ., & Gopalakrishnan, M. . (2022). An exploratory machine learning approach to identify placebo responders in pharmacological binge eating disorder trials. Clinical and Translational Science. https://doi.org/10.1111/cts.13406 (Original work published 2022)